FDA, Covid and vaccines
Digest more
Top News
Overview
Impacts
1️⃣ Grim warning: The world’s ice sheets are on course for runaway melting, leading to multiple feet of sea level rise and “catastrophic” migration. The dire prognosis from a group of international scientists suggests that coastlines will pay the heaviest price .
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.
On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and older, and those with certain medical conditions that put them at high risk for severe infection.
9h
Medpage Today on MSNThese European Countries Give the Chickenpox Vaccine"Again, I don't want to give advice," Kennedy said. "I can tell you, in Europe, they don't use the chickenpox vaccine specifically because the preclinical trial shows that when you inoculate the population for chickenpox, you get shingles in older people, which is more dangerous."
Amid a growing distrust of vaccines and the medical community, there’s also been a growing divide in the Make America Healthy Again initiative.
Explore more
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration.
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get at least one vaccine per year, with those in higher-0
South Korean vaccine company SK Bioscience said it has prevailed in a lawsuit brought by Pfizer that accused it of infringing on the patent for the drugmaker's Prevnar 13 vaccine.